Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CASP6 | P55212 | 1/20 | 0.59 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29627789 | 1.00 | ATM (0.63) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8904619 | 0.83 | ATM (0.48) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8686338 | 0.81 | MEN1 (0.56) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8785964 | 0.81 | POLB (0.68) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8687527 | 0.81 | MEN1 (0.56) | ATMMEN1KMT2APOLBCASP6 | |
| Carbamic Acid SCHEMBL20269740 | 0.81 | KMT2A (0.50) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL14344280 | 0.79 | KMT2A (0.54) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL3084819 | 0.78 | ATM (1.00) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8787510 | 0.77 | MEN1 (0.57) | ATMMEN1KMT2APOLBCASP6 | |
| SCHEMBL8785577 | 0.77 | KMT2A (0.57) | ATMMEN1KMT2APOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998027969-A2 | ANTIMICROBIAL PHENAZINE COMPOUNDS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-07-02 | — | — | WO | claimed |
| US-5637591-A | TREATMENT OF GINGIVITIS | FUJI IMMUNOPHARMACEUTICALS CORP. (US) | 1997-06-10 | — | — | US | claimed |
| JP-58116474-A | — | — | None | — | — | JP | disclosed |
| JP-58083683-A | — | — | None | — | — | JP | disclosed |
| JP-9100231-A | — | — | None | — | — | JP | disclosed |
| US-20240145765-A1 | ELECTRODE FOR NON-AQUEOUS ELECTROLYTE POWER STORAGE DEVICE, NON-AQUEOUS ELECTROLYTE POWER STORAGE DEVICE, AND METHOD FOR PRODUCING SAME | ATTACCATO LIMITED LIABILITY COMPANY (JP) | 2024-05-02 | — | — | US | disclosed |
| US-11958842-B2 | Substituted phenazines and methods of treating cancer and bacterial diseases | ADJUTEC PHARMA AS (NO) | 2024-04-16 | — | — | US | disclosed |
| CN-114556616-A | Electrode for nonaqueous electrolyte electricity storage device, and method for manufacturing same | ＡＴＴＡＣＣＡＴＯ合同会社 | 2022-05-27 | — | — | CN | disclosed |
| US-20210292313-A1 | SUBSTITUTED PHENAZINES AND METHODS OF TREATING CANCER AND BACTERIAL DISEASES | Rongved, Pål (NO) | 2021-09-23 | — | — | US | disclosed |
| CN-113169293-A | Electrode for nonaqueous electrolyte battery and nonaqueous electrolyte battery | ＡＴＴＡＣＣＡＴＯ合同会社 | 2021-07-23 | — | — | CN | disclosed |
| US-11046678-B2 | Substituted phenazines and methods of treating cancer and bacterial diseases | Rongved, Pål (NO) | 2021-06-29 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | disclosed |
| US-4537776-A | PERCUTANEOUS DELIVERY OF ANTIINFLAMMATORY AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0129285-A2 | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl)pyrrolidone | THE PROCTER & GAMBLE COMPANY (US) | 1984-12-27 | — | — | EP | disclosed |
| EP-0129284-A2 | Improved penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | THE PROCTER & GAMBLE COMPANY (US) | 1984-12-27 | — | — | EP | disclosed |
| JP-S58116474-A | PREPARATION OF PHENAZINE OXIDE | TORAY IND INC | 1983-07-11 | — | — | JP | disclosed |
| JP-S5883683-A | PREPARATION OF PHENAZINE-5-OXIDE | TORAY IND INC | 1983-05-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958842-B2 | Substituted phenazines and methods of treating cancer and bacterial diseases | TLR5, TOP2A, SCN5A | ATM 1604/4885MEN1 212/4885KMT2A 953/4885 |
| US-20210292313-A1 | SUBSTITUTED PHENAZINES AND METHODS OF TREATING CANCER AND BACTERIAL DISEASES | TLR5, TOP2A, SCN5A | ATM 1604/4885MEN1 212/4885KMT2A 953/4885 |
| US-11046678-B2 | Substituted phenazines and methods of treating cancer and bacterial diseases | NRAS, ABCB11, APC | ATM 2198/4885MEN1 429/4885KMT2A 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.